These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23485389)

  • 1. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults.
    Sun D; Dorman S; Shah M; Manabe YC; Moodley VM; Nicol MP; Dowdy DW
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):552-8. PubMed ID: 23485389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
    Yakhelef N; Audibert M; Ferlazzo G; Sitienei J; Wanjala S; Varaine F; Bonnet M; Huerga H
    PLoS One; 2020; 15(1):e0227138. PubMed ID: 31999746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
    BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting-A cost-effectiveness analysis.
    Fekadu G; Wang Y; You JHS
    PLoS One; 2023; 18(7):e0288605. PubMed ID: 37450476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of point-of-care lateral flow urine lipoarabinomannan antigen testing in HIV-positive adults in South Africa.
    Mukora R; Tlali M; Monkwe S; Charalambous S; Karat AS; Fielding KL; Grant AD; Vassall A
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1082-1087. PubMed ID: 30092876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.
    Reddy KP; Gupta-Wright A; Fielding KL; Costantini S; Zheng A; Corbett EL; Yu L; van Oosterhout JJ; Resch SC; Wilson DP; Horsburgh CR; Wood R; Alufandika-Moyo M; Peters JA; Freedberg KA; Lawn SD; Walensky RP
    Lancet Glob Health; 2019 Feb; 7(2):e200-e208. PubMed ID: 30683239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis.
    Ricks S; Denkinger CM; Schumacher SG; Hallett TB; Arinaminpathy N
    PLoS Med; 2020 Dec; 17(12):e1003466. PubMed ID: 33306694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.
    Shah M; Dowdy D; Joloba M; Ssengooba W; Manabe YC; Ellner J; Dorman SE
    AIDS; 2013 Nov; 27(18):2883-92. PubMed ID: 25119690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
    Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa.
    Kerkhoff AD; Longley N; Kelly N; Cross A; Vogt M; Wood R; Hermans S; Lawn SD; Harrison TS
    BMC Infect Dis; 2020 Jul; 20(1):555. PubMed ID: 32736601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
    Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson J
    BMC Med; 2017 Aug; 15(1):145. PubMed ID: 28774293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis.
    Schnippel K; Firnhaber C; Conradie F; Ndjeka N; Sinanovic E
    Appl Health Econ Health Policy; 2018 Feb; 16(1):43-54. PubMed ID: 28980217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature Review.
    de Siqueira-Filha NT; Legood R; Cavalcanti A; Santos AC
    Value Health; 2018 Apr; 21(4):482-490. PubMed ID: 29680106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.
    Nakiyingi L; Moodley VM; Manabe YC; Nicol MP; Holshouser M; Armstrong DT; Zemanay W; Sikhondze W; Mbabazi O; Nonyane BA; Shah M; Joloba ML; Alland D; Ellner JJ; Dorman SE
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):270-9. PubMed ID: 24675585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Tuberculosis Screening via a Mobile Health App in Myanmar: Incremental Cost-Effectiveness Evaluation.
    Htet KKK; Phyu AN; Zayar NN; Chongsuvivatwong V
    JMIR Form Res; 2023 Nov; 7():e51998. PubMed ID: 37948119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa.
    d'Elia A; Evans D; McNamara L; Berhanu R; Sanne I; Lönnermark E
    Pan Afr Med J; 2015; 22():4. PubMed ID: 26600904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.